Altered Cytotoxicity Profile of CD8+ T cells in Ankylosing Spondylitis.
Ankylosing spondylitis (AS) is an inflammatory arthritis in which males have a higher risk of developing progressive axial disease than females. Transcriptomic studies have observed reduced expression of cytotoxic cell genes in the blood of AS patients. HLA-B27 contributes the greatest risk for AS, suggesting a role for CD8+ T cells. Here we sought to profile AS patient cytotoxic cells with the hypothesis that an alteration in CD8+ T cells might explain the aberrant cytotoxic profile observed in patients. Whole blood was examined for granzyme (GZM) and perforin (PRF1) gene expression by qPCR. Serum and synovial fluid (SF) was examined for GZM/PRF1 expression by bead array. Blood and SF mononuclear cells were examined for phenotype and GZM/PRF1 expression by FACS. GZM and PRF1 gene expression were both reduced in AS patients, especially in males. PRF1 protein, but not GZM, was reduced in AS patient serum. GZMs were elevated in AS synovial fluid, but not in rheumatoid arthritis or osteoarthritis SF. FACS revealed a reduction in GZM+ and PRF1+ lymphocytes, but not an intrinsic defect in CD8+ T cell GZM/PRF1 production. On the contrary, CD8+ T cell frequency was reduced in the blood and increased in the SF of AS patients. AS patients have an altered cytotoxic T cell profile. This data suggests that CD8+ T cells with a cytotoxic phenotype are being recruited to the joints, where they possess an activated phenotype. Thus, a central role for CD8+ T cells in AS may have been overlooked and deserves further study.